Company intelligence / Profile preview

EQT Life Sciences

Ownership: Private
Employees: ~30
Development stage: Other

Overview

EQT Life Sciences has invested in over 150 innovative life sciences and healthcare companies globally. It focuses on supporting startups and growth-stage firms developing therapeutics (including small molecules and biologics), medical devices, diagnostics and healthtech solutions that address significant unmet clinical needs. The firm provides capital as well as strategic guidance from its team of medical and scientific experts.

Therapeutic areas: OncologyRare DiseasesNeurologyInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyGene therapyMedical deviceDiagnostic technology
Industry: Investors

Partnerships

Novartis Venture FundsSanofi Ventures

Beyond the preview

Go deeper on EQT Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EQT Life Sciences.

Explore the full profile